Related Experiment Video
Updated: Jul 1, 2026
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating
Wen-Hua Chung1, Chi-Fen Chang2, Chao-Yuan Huang3
1Department of Pharmacy, China Medical University, Taichung, Taiwan, R.O.C.
Background/Aim:
Notch signaling exerts context-dependent effects in cancer; however, the prognostic relevance of inherited variation in Notch-related genes in prostate cancer remains unclear. We investigated whether germline single-nucleotide polymorphisms (SNPs) in Notch pathway genes are associated with clinical outcomes in men receiving androgen deprivation therapy (ADT).
Patients And Methods:
We genotyped 222 SNPs across 24 Notch pathway-related genes in 630 patients with advanced prostate cancer. Associations with cancer-specific survival (CSS) and overall survival (OS) were assessed using Cox proportional hazards models. Integrative bioinformatics analyses, including pooled transcriptomic dataset analysis, expression quantitative trait locus analysis, and pathway enrichment, were performed to assess functional relevance.
Results:
Multiple SNPs were significantly associated with CSS and OS, with Yes1-associated transcriptional regulator (YAP1) rs1894116 showing the strongest prognostic signal. The minor G allele was associated with a 26% reduction in prostate cancer-specific mortality and a 22% reduction in all-cause mortality, independent of established clinical predictors. Functional annotation suggested that rs1894116 may be linked to increased YAP1 expression. Pooled transcriptomic analyses showed lower YAP1 expression in tumors than in normal tissue, while higher YAP1 expression correlated with more favorable outcomes. YAP1-correlated genes were enriched in the focal adhesion pathway, suggesting a tumor-suppressive YAP1-focal adhesion axis, particularly involving vinculin.
Conclusion:
Germline variation in the Notch-YAP axis, notably YAP1 rs1894116, predicts survival in patients with prostate cancer treated with ADT. Elevated YAP1 expression and coordinated activation of focal adhesion components may be associated with less aggressive disease. These findings provide mechanistic insight into Notch signaling in prostate cancer and highlight YAP1 and its variants as potential biomarkers for risk stratification and personalized therapy.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...